The global microbiome sequencing services market is broadly segmented by technology, application, research type, laboratory type, end user, and region. On the basis of technology, the market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and other technologies (such as Omic technologies). The sequencing by synthesis segment is expected to grow at the highest CAGR of the market in 2016.
https://www.marketsandmarkets.com/Market-Reports/microbiome-sequencing-service-market-94324380.html
Drivers
1 Increased Focus on Human Microbiome Therapy
2 Human Microbiome as New Validated Target for Drug Development
3 Human Microbiome for Early Disease Detection and Diagnosis
Restraints
1 Lack of Expertise and Detailed Research
2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
Opportunities
1 Investigational New Drug (IND) Requirements for Fecal Microbiota
2 Increasing Collaborations Create Growth Opportunities
PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=94324380
Burning Issues
1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
2 Development of Human Microbiome Therapeutic Products
North America is expected to have the highest CAGR in the global microbiome sequencing services in 2016. Factors such as favorable business environment, government support through funds for genomics research, continuous developments in sequencing technologies, availability of commercial solutions for NGS data analysis, growing number of research studies on cancer & inherited rare diseases drive the growth of the market in this region.